US Stock MarketDetailed Quotes

Citius Pharmaceuticals (CTXR)

Watchlist
  • 0.7700
  • -0.1630-17.47%
Close Apr 24 16:00 ET
  • 0.7599
  • -0.0101-1.31%
Post 20:01 ET
17.23MMarket Cap-0.31P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Citius Pharmaceuticals (CTXR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-175.27%-13.01M
5.85%-26.55M
-100.94%-11.88M
35.38%-5.41M
41.70%-4.54M
22.97%-4.73M
2.96%-28.2M
13.05%-5.91M
12.68%-8.37M
0.85%-7.79M
Net income from continuing operations
8.63%-9.39M
-0.80%-39.74M
21.07%-8.74M
12.95%-9.2M
-34.73%-11.51M
-11.38%-10.28M
-21.15%-39.43M
-11.40%-11.08M
-24.70%-10.57M
18.83%-8.54M
Operating gains losses
--68.6K
----
----
----
----
----
----
----
----
----
Depreciation and amortization
-130.06%-16.48K
2.21%214.25K
15.56%62.04K
-21.72%41.37K
7.57%56.01K
7.50%54.84K
7.87%209.61K
7.44%53.69K
7.82%52.85K
8.16%52.07K
Deferred tax
0.00%264.24K
83.50%1.06M
83.50%264.24K
83.50%264.24K
83.50%264.24K
83.50%264.24K
0.00%576K
0.00%144K
0.00%144K
0.00%144K
Other non cash items
--680.95K
-90.64%26.6K
----
----
----
----
178.60%284.18K
--1
--109.95K
--98.08K
Change In working capital
-427.95%-8.89M
162.52%1.05M
-374.35%-6.38M
166.40%771.97K
251.08%3.95M
1,261.42%2.71M
57.94%-1.69M
1,942.79%2.33M
52.94%-1.16M
-315.48%-2.61M
-Change in receivables
---4.05M
----
----
----
----
--0
----
----
----
----
-Change in inventory
94.23%-352.65K
-492.78%-12.65M
-73.82%-3.71M
---1.87M
---957.88K
---6.11M
---2.13M
---2.13M
--0
--0
-Change in prepaid assets
-1,368.24%-2.14M
93.21%-64.21K
-215.19%-1.45M
256.93%1.7M
85.82%-163.05K
-682.72%-145.74K
81.23%-945.39K
2,302.82%1.26M
45.89%-1.08M
-183.52%-1.15M
-Change in payables and accrued expense
-125.04%-2.17M
739.91%12.94M
-126.87%-733.77K
177.48%470.24K
4,490.29%4.54M
1,906.53%8.66M
84.98%1.54M
579.94%2.73M
39.55%-606.89K
-104.30%-103.44K
-Change in other current liabilities
128.09%16.37K
-8.20%-236.29K
-19.65%-68.38K
8.53%-50.14K
-10.67%-59.47K
-10.67%-58.3K
-10.86%-218.38K
-10.67%-57.15K
-10.93%-54.82K
-10.93%-53.74K
-Change in other working capital
-154.10%-198.05K
1,376.27%1.06M
-179.34%-417.59K
-9.25%525.98K
145.04%588.98K
33.76%366.07K
-81.75%72.04K
-4.57%526.35K
-0.01%579.59K
---1.31M
Cash from discontinued investing activities
Operating cash flow
-175.27%-13.01M
5.85%-26.55M
-100.94%-11.88M
35.38%-5.41M
41.70%-4.54M
22.97%-4.73M
2.96%-28.2M
13.05%-5.91M
12.68%-8.37M
0.85%-7.79M
Investing cash flow
Cash flow from continuing investing activities
-4.4M
-15.00%-5.75M
0
-5M
Net other investing changes
---4.4M
-15.00%-5.75M
----
----
----
----
---5M
----
----
----
Cash from discontinued investing activities
Investing cash flow
---4.4M
-15.00%-5.75M
----
----
----
--0
---5M
----
----
----
Financing cash flow
Cash flow from continuing financing activities
711.09%20.88M
233.96%33.3M
521.55%15.79M
-16.40%11.47M
3.47M
2.57M
-27.89%9.97M
-545,260.12%-3.75M
13.72M
0
Net issuance payments of debt
----
--1.3M
--0
----
----
----
--0
--0
----
----
Net common stock issuance
711.09%20.88M
134.02%32.3M
18,539.67%15.79M
-23.69%10.47M
--3.47M
--2.57M
0.04%13.8M
365.17%84.73K
--13.72M
--0
Proceeds from stock option exercised by employees
----
----
----
----
----
----
--0
----
----
----
Net other financing activities
----
92.17%-300K
--0
----
----
----
---3.83M
----
----
----
Cash from discontinued financing activities
Financing cash flow
711.09%20.88M
233.96%33.3M
521.55%15.79M
-16.40%11.47M
--3.47M
--2.57M
-27.89%9.97M
-545,260.12%-3.75M
-0.58%13.72M
--0
Net cash flow
Beginning cash position
30.76%4.25M
-87.72%3.25M
-66.00%6.09M
-99.79%26.41K
-94.59%1.1M
-87.72%3.25M
-36.51%26.48M
-46.18%17.91M
-56.79%12.56M
-44.84%20.35M
Current changes in cash
261.22%3.47M
104.31%1M
87.47%-1.84M
13.29%6.06M
86.21%-1.07M
64.93%-2.15M
-52.51%-23.23M
-115.55%-14.66M
26.93%5.35M
0.46%-7.79M
End cash Position
601.89%7.72M
30.76%4.25M
30.76%4.25M
-66.00%6.09M
-99.79%26.41K
-94.59%1.1M
-87.72%3.25M
-87.72%3.25M
-46.18%17.91M
-56.79%12.56M
Free cash flow
-175.27%-13.01M
5.85%-26.55M
-100.94%-11.88M
35.38%-5.41M
41.70%-4.54M
22.97%-4.73M
2.96%-28.2M
13.05%-5.91M
12.68%-8.37M
0.85%-7.79M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -175.27%-13.01M5.85%-26.55M-100.94%-11.88M35.38%-5.41M41.70%-4.54M22.97%-4.73M2.96%-28.2M13.05%-5.91M12.68%-8.37M0.85%-7.79M
Net income from continuing operations 8.63%-9.39M-0.80%-39.74M21.07%-8.74M12.95%-9.2M-34.73%-11.51M-11.38%-10.28M-21.15%-39.43M-11.40%-11.08M-24.70%-10.57M18.83%-8.54M
Operating gains losses --68.6K------------------------------------
Depreciation and amortization -130.06%-16.48K2.21%214.25K15.56%62.04K-21.72%41.37K7.57%56.01K7.50%54.84K7.87%209.61K7.44%53.69K7.82%52.85K8.16%52.07K
Deferred tax 0.00%264.24K83.50%1.06M83.50%264.24K83.50%264.24K83.50%264.24K83.50%264.24K0.00%576K0.00%144K0.00%144K0.00%144K
Other non cash items --680.95K-90.64%26.6K----------------178.60%284.18K--1--109.95K--98.08K
Change In working capital -427.95%-8.89M162.52%1.05M-374.35%-6.38M166.40%771.97K251.08%3.95M1,261.42%2.71M57.94%-1.69M1,942.79%2.33M52.94%-1.16M-315.48%-2.61M
-Change in receivables ---4.05M------------------0----------------
-Change in inventory 94.23%-352.65K-492.78%-12.65M-73.82%-3.71M---1.87M---957.88K---6.11M---2.13M---2.13M--0--0
-Change in prepaid assets -1,368.24%-2.14M93.21%-64.21K-215.19%-1.45M256.93%1.7M85.82%-163.05K-682.72%-145.74K81.23%-945.39K2,302.82%1.26M45.89%-1.08M-183.52%-1.15M
-Change in payables and accrued expense -125.04%-2.17M739.91%12.94M-126.87%-733.77K177.48%470.24K4,490.29%4.54M1,906.53%8.66M84.98%1.54M579.94%2.73M39.55%-606.89K-104.30%-103.44K
-Change in other current liabilities 128.09%16.37K-8.20%-236.29K-19.65%-68.38K8.53%-50.14K-10.67%-59.47K-10.67%-58.3K-10.86%-218.38K-10.67%-57.15K-10.93%-54.82K-10.93%-53.74K
-Change in other working capital -154.10%-198.05K1,376.27%1.06M-179.34%-417.59K-9.25%525.98K145.04%588.98K33.76%366.07K-81.75%72.04K-4.57%526.35K-0.01%579.59K---1.31M
Cash from discontinued investing activities
Operating cash flow -175.27%-13.01M5.85%-26.55M-100.94%-11.88M35.38%-5.41M41.70%-4.54M22.97%-4.73M2.96%-28.2M13.05%-5.91M12.68%-8.37M0.85%-7.79M
Investing cash flow
Cash flow from continuing investing activities -4.4M-15.00%-5.75M0-5M
Net other investing changes ---4.4M-15.00%-5.75M-------------------5M------------
Cash from discontinued investing activities
Investing cash flow ---4.4M-15.00%-5.75M--------------0---5M------------
Financing cash flow
Cash flow from continuing financing activities 711.09%20.88M233.96%33.3M521.55%15.79M-16.40%11.47M3.47M2.57M-27.89%9.97M-545,260.12%-3.75M13.72M0
Net issuance payments of debt ------1.3M--0--------------0--0--------
Net common stock issuance 711.09%20.88M134.02%32.3M18,539.67%15.79M-23.69%10.47M--3.47M--2.57M0.04%13.8M365.17%84.73K--13.72M--0
Proceeds from stock option exercised by employees --------------------------0------------
Net other financing activities ----92.17%-300K--0---------------3.83M------------
Cash from discontinued financing activities
Financing cash flow 711.09%20.88M233.96%33.3M521.55%15.79M-16.40%11.47M--3.47M--2.57M-27.89%9.97M-545,260.12%-3.75M-0.58%13.72M--0
Net cash flow
Beginning cash position 30.76%4.25M-87.72%3.25M-66.00%6.09M-99.79%26.41K-94.59%1.1M-87.72%3.25M-36.51%26.48M-46.18%17.91M-56.79%12.56M-44.84%20.35M
Current changes in cash 261.22%3.47M104.31%1M87.47%-1.84M13.29%6.06M86.21%-1.07M64.93%-2.15M-52.51%-23.23M-115.55%-14.66M26.93%5.35M0.46%-7.79M
End cash Position 601.89%7.72M30.76%4.25M30.76%4.25M-66.00%6.09M-99.79%26.41K-94.59%1.1M-87.72%3.25M-87.72%3.25M-46.18%17.91M-56.79%12.56M
Free cash flow -175.27%-13.01M5.85%-26.55M-100.94%-11.88M35.38%-5.41M41.70%-4.54M22.97%-4.73M2.96%-28.2M13.05%-5.91M12.68%-8.37M0.85%-7.79M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -